Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
iShares MSCI Mexico ETF
EWW
$1.86B
| $2.03M | ﹤0.01% |
+47,600
| New | +$1.99M |
|
|
SNBR
2277
DELISTED
Sleep Number
SNBR
| $2.03M | ﹤0.01% |
+49,100
| New | +$2.1M |
|
|
STI
2278
DELISTED
SunTrust Banks, Inc.
STI
| $2.02M | ﹤0.01% |
29,400
+17,300
| +143% | +$1.11M |
|
|
RNWK
2279
DELISTED
RealNetworks Inc
RNWK
| $2.02M | ﹤0.01% |
1,218,439
+26,016
| +2% | +$42.4K |
|
|
AFI
2280
DELISTED
Armstrong Flooring, Inc.
AFI
| $2.02M | ﹤0.01% |
315,966
+124,866
| +65% | +$975K |
|
2281
Landmark Bancorp
LARK
$196M
| $2.01M | ﹤0.01% |
120,860
+5,770
| +5% | +$96K |
|
|
SMED
2282
DELISTED
Sharps Compliance Corp
SMED
| $2.01M | ﹤0.01% |
484,944
+23,652
| +5% | +$89.5K |
|
2283
Eagle Bancorp
EGBN
$878M
| $2.01M | ﹤0.01% |
45,080
+38,880
| +627% | +$1.7M |
|
2284
Orion Group Holdings
ORN
$402M
| $2.01M | ﹤0.01% |
446,097
-164,998
| -27% | -$684K |
|
2285
Lexicon Pharmaceuticals
LXRX
$1.03B
| $2M | ﹤0.01% |
665,379
+118,638
| +22% | +$367K |
|
2286
Crown Crafts
CRWS
$30.7M
| $2M | ﹤0.01% |
320,000
+11,400
| +4% | +$57.1K |
|
|
GPL
2287
DELISTED
Great Panther Mining Limited
GPL
| $2M | ﹤0.01% |
282,826
-22,460
| -7% | -$180K |
|
2288
Tenable Holdings
TENB
$4.22B
| $1.99M | ﹤0.01% |
+89,100
| New | +$2.26M |
|
|
HNP
2289
DELISTED
Huaneng Power Intl, Inc.
HNP
| $1.98M | ﹤0.01% |
104,000
+24,300
| +30% | +$547K |
|
|
MBCN
2290
DELISTED
Middlefield Banc Corp
MBCN
| $1.98M | ﹤0.01% |
84,418
-5,236
| -6% | -$118K |
|
|
TAST
2291
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $1.98M | ﹤0.01% |
238,200
-207,700
| -47% | -$1.74M |
|
2292
Westamerica Bancorp
WABC
$1.38B
| $1.97M | ﹤0.01% |
31,631
+26,100
| +472% | +$1.62M |
|
|
VVUS
2293
DELISTED
Vivus Inc
VVUS
| $1.96M | ﹤0.01% |
506,645
+78,221
| +18% | +$293K |
|
|
HDV
2294
iShares Core High Dividend ETF
HDV
$15.1B
| $1.95M | ﹤0.01% |
103,500
+45,000
| +77% | +$846K |
|
2295
ImmunityBio
IBRX
$8.02B
| $1.95M | ﹤0.01% |
1,595,725
+83,400
| +6% | +$103K |
|
|
TBI
2296
Trueblue
TBI
$311M
| $1.94M | ﹤0.01% |
92,000
-65,200
| -41% | -$1.35M |
|
2297
Forward Air
FWRD
$640M
| $1.94M | ﹤0.01% |
30,439
-17,300
| -36% | -$1.06M |
|
|
EEI
2298
DELISTED
Ecology and Environment
EEI
| $1.94M | ﹤0.01% |
127,817
+1,300
| +1% | +$15.9K |
|
|
INDT
2299
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $1.94M | ﹤0.01% |
51,100
+5,500
| +12% | +$203K |
|
|
BSCK
2300
DELISTED
Invesco BulletShares 2020 Corporate Bond ETF
BSCK
| $1.93M | ﹤0.01% |
90,654
-44,746
| -33% | -$953K |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.